Procedures were completed in the USA and Europe [28-November-2017] PRINCETON, New Jersey and OR AKIVA, Israel, November 28, 2017 /PRNewswire/ -- Regentis Biomaterials [http://www.regentis.co.il ] announced today the start of its Phase III pivotal clinical trial of GelrinC for the treatment of focal knee cartilage defects with successful surgery
November 28, 2017
· 3 min read